Gryphon Digital Mining (GRYP) S-1 10 Aug 20 IPO registration Financial data

Document and Entity Information

Document and Entity Information	9 Months Ended
	Mar. 31, 2020
Document and Entity Information [Abstract]
Entity Registrant Name	Akerna Corp.
Entity Central Index Key	0001755953
Amendment Flag	false
Document Type	S-1
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Incorporation State Country Code	DE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (unaudited) - USD ($)	Mar. 31, 2020	Jun. 30, 2019
Current assets
Cash	$ 14,309,996	$ 21,867,289
Restricted cash	500,000	500,000
Accounts receivable, net	1,324,051	1,257,274
Prepaid expenses and other current assets	1,762,371	577,674
Total current assets	17,896,418	24,202,237
Intangible and other assets	23,136,584
Fixed assets, net	65,582
Investment	250,000
Total assets	41,348,584	24,202,237
Current liabilities
Accounts payable and accrued liabilities	4,025,199	1,818,116
Deferred revenue	743,317	624,387
Total current liabilities	4,768,516	2,442,503
Commitments and contingencies (Note 6)
Equity:
Preferred stock, par value $0.0001; 5,000,000 shares authorized, none are issued and outstanding at March 31, 2020 and June 30, 2019
Common stock, par value $0.0001; 75,000,000 shares authorized, 12,856,302 issued and outstanding at March 31, 2020, and 10,589,746 shares issued and outstanding at June 30, 2019	1,286	1,059
Additional paid-in capital	69,916,857	47,325,421
Accumulated deficit	(38,100,333)	(25,566,746)
Total stockholders' equity	31,817,810	21,759,734
Noncontrolling interests in consolidated subsidiary	4,762,258
Total equity	36,580,068	21,759,734
Total liabilities and equity	$ 41,348,584	$ 24,202,237

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - $ / shares	Mar. 31, 2020	Jun. 30, 2019
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	12,856,302	10,589,746
Common stock, shares outstanding	12,856,302	10,589,746

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Revenues
Software	$ 2,346,310	$ 2,024,916	$ 7,148,964	$ 6,174,102
Consulting	692,584	216,897	2,248,947	826,777
Other	31,652	86,067	171,727	200,312
Total revenues	3,070,546	2,327,880	9,569,638	7,201,191
Cost of revenues	1,420,909	1,166,482	4,457,110	3,550,612
Gross profit	1,649,637	1,161,398	5,112,528	3,650,579
Operating expenses
Product development	1,632,353	1,001,394	4,024,743	2,877,869
Selling, general and administrative	5,500,837	2,663,171	13,881,055	7,440,115
Total operating expenses	7,133,190	3,664,565	17,905,798	10,317,984
Loss from operations	(5,483,553)	(2,503,167)	(12,793,270)	(6,667,405)
Other income (expense)
Interest	33,522	20,914	158,762	69,265
Other	(124)	(7,850)	(254)	17,983
Total other income	33,398	13,064	158,508	87,248
Net loss	(5,450,155)	(2,490,103)	(12,634,762)	(6,580,157)
Net loss attributable to noncontrolling interests in consolidated subsidiary	101,175		101,175
Net loss attributable to Akerna stockholders	$ (5,348,980)	$ (2,490,103)	$ (12,533,587)	$ (6,580,157)
Basic and diluted weighted average common stock outstanding	12,469,737	6,022,026	11,299,997	5,843,334
Basic and diluted net loss per common share	$ (0.43)	$ (0.41)	$ (1.11)	$ (1.13)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total	Noncontrolling Interests in Consolidated Subsidiary	Total Equity
Balance at Jun. 30, 2018	$ 492	$ 14,563,102	$ (13,163,531)	$ 1,400,063
Balance shares at Jun. 30, 2018	4,922,650
Issuance of shares in exchange for cash	$ 110	9,999,890		10,000,000
Issuance of shares in exchange for cash, shares	1,099,376
Net loss			(1,695,683)	(1,695,683)
Balance at Sep. 30, 2018	$ 602	24,562,992	(14,859,214)	9,704,380
Balance shares at Sep. 30, 2018	6,022,026
Balance at Jun. 30, 2018	$ 492	14,563,102	(13,163,531)	1,400,063
Balance shares at Jun. 30, 2018	4,922,650
Net loss				(6,580,157)
Balance at Mar. 31, 2019	$ 602	24,562,992	(19,743,688)	(4,819,906)
Balance shares at Mar. 31, 2019	6,022,026
Balance at Sep. 30, 2018	$ 602	24,562,992	(14,859,214)	9,704,380
Balance shares at Sep. 30, 2018	6,022,026
Net loss			(2,394,371)	(2,394,371)
Balance at Dec. 31, 2018	$ 602	24,562,992	(17,253,585)	7,310,009
Balance shares at Dec. 31, 2018	6,022,026
Net loss			(2,490,103)	(2,490,103)
Balance at Mar. 31, 2019	$ 602	24,562,992	(19,743,688)	(4,819,906)
Balance shares at Mar. 31, 2019	6,022,026
Balance at Jun. 30, 2019	$ 1,059	47,325,421	(25,566,746)	21,759,734		$ 21,759,734
Balance shares at Jun. 30, 2019	10,589,746
Cash received in connection with exercise of warrants	$ 37	4,242,417		4,242,454		4,242,454
Cash received in connection with exercise of warrants, shares	368,910
Stock-based compensation		161,165		161,165		161,165
Net loss			(2,846,071)	(2,846,071)		(2,846,071)
Balance at Sep. 30, 2019	$ 1,096	51,729,003	(28,412,817)	23,317,282		23,317,282
Balance shares at Sep. 30, 2019	10,958,656
Balance at Jun. 30, 2019	$ 1,059	47,325,421	(25,566,746)	21,759,734		21,759,734
Balance shares at Jun. 30, 2019	10,589,746
Net loss				(12,634,762)
Balance at Mar. 31, 2020	$ 1,286	69,916,857	(38,100,333)	31,817,810	4,762,258	36,580,068
Balance shares at Mar. 31, 2020	12,856,302
Balance at Sep. 30, 2019	$ 1,096	51,729,003	(28,412,817)	23,317,282		23,317,282
Balance shares at Sep. 30, 2019	10,958,656
Cash received in connection with exercise of warrants		4,611		4,611		4,611
Cash received in connection with exercise of warrants, shares	401
Stock-based compensation		331,485		331,485		331,485
Forfeitures of restricted shares	$ (3)	3
Forfeitures of restricted shares, shares	(37,572)
Net loss			(4,338,536)	(4,338,536)		(4,338,536)
Balance at Dec. 31, 2019	$ 1,093	52,065,102	(32,751,353)	19,314,842		19,314,842
Balance shares at Dec. 31, 2019	10,921,485
Common shares issued in exchange for interest in consolidated subsidiary	$ 195	17,549,805		17,550,000		17,550,000
Common shares issued in exchange for interest in consolidated subsidiary, Shares	1,950,000
Noncontrolling interests in acquired subsidiary					4,863,433	4,863,433
Stock-based compensation		301,948		301,948		301,948
Forfeitures of restricted shares	$ (2)	2
Forfeitures of restricted shares, shares	(15,183)
Net loss			(5,348,980)	(5,450,155)	(101,175)	(5,450,155)
Balance at Mar. 31, 2020	$ 1,286	$ 69,916,857	$ (38,100,333)	$ 31,817,810	$ 4,762,258	$ 36,580,068
Balance shares at Mar. 31, 2020	12,856,302

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities
Net loss	$ (12,634,762)	$ (6,580,157)
Adjustment to reconcile net loss to net cash used in operating activities:
Bad debt expense	933,079	156,115
Stock-based compensation expense	794,598
Depreciation and amortization	2,824
Changes in operating assets and liabilities:
Accounts receivable	(986,808)	(1,394,378)
Prepaid expenses and other current assets	(1,162,562)	(204,991)
Other assets	(58,925)
Accounts payable and accrued liabilities	1,391,549	1,229,298
Deferred revenue	118,930	436,178
Net cash used in operating activities	(11,602,077)	(6,357,935)
Cash flows from investing activities
Furniture, fixtures and equipment additions	(53,621)
Cash acquired in business combination	101,340
Purchase of equity method investment	(250,000)
Net cash used in investing activities	(202,281)
Cash flows from financing activities
Cash received in connection with exercise of warrants	4,247,065
Cash received in connection with issuance of shares		10,000,000
Net cash provided by financing activities	4,247,065	10,000,000
Net change in cash and restricted cash	(7,557,293)	3,642,065
Cash and restricted cash - beginning of period	22,367,289	2,572,401
Cash and restricted cash - end of period	$ 14,809,996	$ 6,214,466

Description of Business, Liquid

Description of Business, Liquidity and Capital Resources	9 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business, Liquidity and Capital Resources	Note 1 - Description of Business, Liquidity and Capital Resources Description of Business Akerna Corp., herein referred to as the Company, we, our or Akerna, through our wholly owned subsidiary MJ Freeway, LLC, or MJF, provides enterprise software solutions that enable regulatory compliance and inventory management. Our proprietary, broad and growing suite of solutions are adaptable for industries in which interfacing with government regulatory agencies for compliance purposes is required, or where the tracking of organic materials from seed or plant to end products is desired. We developed products intended to assist states in monitoring licensed businesses' compliance with state regulations, and to help state-licensed businesses operate in compliance with such law. We provide our regulatory software platform, Leaf Data Systems®, to state government regulatory agencies, and our commercial software platform, MJ Platform®, to state-licensed businesses. Through our controlled subsidiary, solo sciences inc., we provide an innovative, next-generation solution for state and national governments to securely track product and waste throughout the supply chain with solo*TAG ™ ™ We consult with clients on a wide range of areas to help them maintain compliance with state law. Our project-focused consulting services help clients obtain licensing to initiate or expand their business operations. Our advisory engagements include service offerings focused on compliance requirement assessments, readiness and best practices, compliance monitoring systems, application processes, inspection readiness and business plan and compliance reviews. We typically provide our consulting services to clients in emerging markets that are seeking consultation on newly introduced licensing regimes and assistance with the regulatory compliant build-out of operations. The accompanying financial statements and related notes reflect the historical results of MJF prior to the mergers completed in June 2019, or the Mergers, with MTech Acquisition Corp., or MTech, and other related entities, which resulted in the combined company, and do not include the historical results of MTech prior to the completion of the Mergers. Liquidity and Capital Resources Since our inception, we have incurred recurring operating losses, used cash from operations, and relied on capital raising transactions to continue ongoing operations. Although we have continuing negative cash flow from operations, the cash outflow since the Mergers is partially attributable to approximately $1.8 million in costs incurred in connection with specific transactions, including the Mergers and acquisitions completed or expected to close within the next twelve months. The transaction costs we expect to occur over the next twelve months are far less than the costs incurred during the nine months ended March 31, 2020. In addition, we are implementing a cost reduction plan during the fourth quarter 2020 that we expect to reduce recurring operating expenses between $2 million and $3 million annually. We anticipate our current cash will be sufficient to meet the working capital requirements for the next twelve months. From time to time, we may pursue various strategic business opportunities. These opportunities may include investment in or ownership of additional technology companies through direct investments, acquisitions, joint ventures and other arrangements. We can provide no assurance that we will successfully identify such opportunities or that, if we identify and pursue any of these opportunities, any of them will be consummated. Consequently, we may raise additional equity or debt capital or enter into arrangements to secure necessary financing to fund the completion of such strategic business opportunities, although no assurance can be provided that we will be successful in completing a future capital raise. The sale of additional equity could result in additional dilution to our existing stockholders, and financing arrangements may not be available to us, or may not be available in sufficient amounts or on acceptable terms. Our future operating performance will be subject to future economic conditions and to financial, business and other factors, many of which are beyond our control.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. Certain footnotes and other financial information normally required by accounting principles generally accepted in the United States of America, or GAAP, have been condensed or omitted in accordance with such rules and regulations. In management's opinion, these condensed consolidated financial statements have been prepared on the same basis as our annual consolidated financial statements and notes thereto and include all adjustments, consisting of normal recurring items, considered necessary for the fair presentation. The operating results for the three and nine months ended March 31, 2020 are not necessarily indicative of the results that may be expected for the year ending June 30, 2020. The condensed consolidated balance sheet for the year ended June 30, 2019 has been derived from our audited financial statements at that date but does not include all disclosures and financial information required by GAAP for complete financial statements. The information included in this quarterly report on Form 10-Q should be read in conjunction with our consolidated financial statements and notes thereto for the year ended June 30, 2019, which were included in our annual report on Form 10-K filed on September 23, 2019. Principles of Consolidation Our accompanying condensed consolidated financial statements include the accounts of Akerna, our wholly owned subsidiaries and those entities in which we otherwise have a controlling financial interest. All significant intercompany balances and transactions have been eliminated in consolidation. We evaluate our ownership interests, contractual rights and other interests in entities to determine if the entities are variable interest entities, or VIEs, when we have a variable interest in those entities. Generally, a VIE is a legal entity in which the equity investors do not have the characteristics of a controlling financial interest or the equity investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support. These evaluations can be complex and involve judgment and the use of estimates and assumptions based on available historical information. If we determine that we hold a variable interest in a VIE and we are the primary beneficiary of the VIE, we must consolidate the VIE in our financial statements. In determining whether we are the primary beneficiary of a VIE, we consider qualitative and quantitative factors, including, but not limited to: which activities most significantly impact the VIE's economic performance and which party controls such activities; the amount and characteristics of our investment; the obligation or likelihood for us or other investors to provide financial support; and the similarity with and significance to our business activities and the business activities of the other investors. Significant judgments related to these determinations include estimates about the current and future fair values and performance of these VIE's operations and general market conditions. We determine whether we are the primary beneficiary of a VIE upon our initial involvement with the VIE and reassess our status on an ongoing basis. Use of Estimates The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the financial statements and accompanying notes thereto. Actual results could differ materially from those estimates. Accounts Receivable, Net We maintain an allowance for doubtful accounts equal to the estimated uncollectible amounts based on our historical collection experience and review of the current status of trade accounts receivable. The allowance for doubtful accounts was $0.5 million as March 31, 2020 and $0.2 million as of June 30, 2019. Concentrations of Credit Risk We grant credit in the normal course of business to our customers. We periodically perform credit analysis and monitor the financial condition of our customers to reduce credit risk. During the three months ended March 31, 2020, one government customer accounted for 25% of total revenues. At March 31, 2020, the same government customer and one other government customer accounted for 24% and 16% of net accounts receivable, respectively. During the three months ended March 31, 2019, one government customer accounted for 33% of total revenues. At June 30, 2019, the same government customer and one other government customer accounted for 33% and 24% of net accounts receivable, respectively. During the nine months ended March 31, 2020, one government customer accounted for 24% and one consulting customer accounted for 11% of total revenues. During the nine months ended March 31, 2019, two government customers accounted for 35% and 11% of total revenues, respectively. Equity Method Investments We make strategic investments in privately held equity securities of companies who provide technology solutions that are complementary to ours. When we can exert significant influence over, but do not control, the investee's operations, through voting rights or representation on the investee's board of directors, we account for the investment using the equity method of accounting. We record our share in the investee's earnings in the consolidated statement of operations. We assess our investment for other-than-temporary impairment when events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable and recognize an impairment loss to adjust the investment to its then current fair value. Intangible Assets Acquired through Business Combinations Intangible assets are amortized over their estimated useful lives. We evaluate the estimated remaining useful life of our intangible assets when events or changes in circumstances indicate an adjustment to the remaining amortization may be needed. We similarly evaluate the recoverability of these assets upon events or changes in circumstances indicate a potential impairment. Recoverability of these assets is measured by comparing the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate. If the undiscounted cash flows used in the test for recoverability are less than the carrying amount of these assets, the carrying amount of such assets is reduced to fair value. There were no impairments of intangible assets during the nine months ended March 31, 2020 or 2019. Goodwill Impairment Assessment We evaluate and test the recoverability of our goodwill for impairment at least annually during the second quarter of each fiscal year or more often if circumstances indicate that goodwill may not be recoverable. Business Combinations We use our best estimates and assumptions to assign fair value to the tangible and intangible assets acquired and liabilities assumed at the acquisition date. Our estimates are inherently uncertain and subject to refinement. During the measurement period, which may be up to one year from the acquisition date, we continue to collect information and reevaluate these estimates and assumptions quarterly and record any adjustments to our preliminary estimates to goodwill. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded in our condensed consolidated statement of operations. In the event we acquire an entity with which we have a preexisting relationship, we will recognize a gain or loss to settle that relationship as of the acquisition date within the condensed consolidated statements of operations. In the event that we acquire an entity in which we previously held a noncontrolling interest, the difference between the fair value of the shares as of the date of the acquisition and the carrying value of our investment is recorded as a gain or loss in the condensed consolidated statement of operations. Revenue Recognition We derive our revenues primarily from the following sources: software revenues, which are primarily comprised of subscription fees from government and commercial customers accessing our enterprise cloud computing services and from customers paying for additional support beyond the standard support that is included in the basic subscription fees; and consulting services provided to operators interested in integrating our platform into their respective operations, such services include: assessing compliance requirements, monitoring systems and readiness; assisting with the application process; and evaluating the operator's inspection readiness and business plan. We commence revenue recognition when there is persuasive evidence of an arrangement, the service has been or is being provided to the customer, the collection of the fees is reasonably assured, and the amount of fees to be paid by the customer is fixed or determinable. Software Revenue Software revenue primarily consists of subscription revenue that is recognized ratably over the term of the contractual period, beginning when access to the applicable software is provided to the customer. We typically invoice customers at the beginning of the term, in multi-year, annual, quarterly, or monthly installments. When collection of fees occurs in advance of service delivery, revenue recognition is deferred until such services are delivered. Revenue for implementation fees is recognized ratably over the expected term of the agreement, including expected renewals. We include service level commitments to customers warranting certain levels of uptime reliability and performance and permitting those customers to receive credits if those levels are not met. In addition, customer contracts often include: specific obligations that require us to maintain the availability of the customer's data through the service and that customer content is secured against unauthorized access or loss; and indemnity provisions whereby we indemnify customers from third-party claims asserted against them that result from our failure to maintain the availability of their content or securing the same from unauthorized access or loss. To date, we have not incurred any material costs as a result of such commitments. Any such credits or payments made to customers under these arrangements are recorded as a reduction of revenue. Consulting Services Revenue Consulting services revenue consists of contracts with fixed terms and fee structures based upon the volume and activity, or fixed price contracts for consulting and strategic services. When these services are not combined with subscription revenues as a single unit of account, as discussed below, these revenues are recognized as services are rendered and accepted by the customer. Other Revenues From time to time, we purchase equipment for resale to customers. Such equipment is generally drop-shipped to our customers. We recognize revenue as the products are delivered. Cost of Revenue Cost of revenue consists primarily of costs related to providing subscription and other services to our customers, including employee compensation and related expenses for datacenter operations, customer support and professional services personnel, payments to outside technology service providers, security services and other tools. Deferred Revenue Deferred revenue primarily consists of payments received in advance of revenue recognition from subscription services described above and is recognized as the revenue recognition criteria are met. The deferred revenue balance is influenced by several factors, including seasonality, the compounding effects of renewals, invoice duration, invoice timing, size and new business within the year. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as deferred revenue, which is a current liability on the accompany condensed consolidated balance sheets. Supplemental Information Regarding Noncash Investing and Financing Activities During the nine months ended March 31, 2020, we acquired 80.4% of the outstanding equity interest in solo sciences inc., or Solo, in exchange for Akerna common stock valued at $17.6 million, please refer to Note 3 for additional information about the transaction and a schedule of the assets acquired and liabilities assumed in conjunction with this transaction. Reclassifications Certain prior year financial statement amounts have been reclassified for consistency with the current year presentation. Recent Accounting Pronouncements The Financial Accounting Standards Board, or the FASB, has issued guidance to revise accounting for revenue from contracts with customers, which supersedes the revenue recognition requirements and industry-specific guidance currently in effect for us. The new revenue standard requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. The new revenue standard is effective for our fiscal 2020 annual reporting period and for interim periods thereafter. The new revenue standard allows for either full retrospective or modified retrospective adoption. We will adopt the new standard using the modified retrospective approach and anticipate that the timing of recognition of incremental costs of obtaining contracts will be the most significant change to our results of operations upon adoption. The FASB has issued new guidance related to the accounting for leases. The new standard establishes a right-of-use model that requires a lessee to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statement of operations. The new standard is effective for us in our fiscal year beginning in 2021. We are evaluating the impact of adoption of the new standard on our consolidated financial statements and do not anticipate a significant impact to our results of operations. The FASB has issued guidance to introduce a new model for recognizing credit losses on financial instruments based on estimated current expected credit losses, or CECL. Under the new standard, an entity is required to estimate CECL on trade receivables at inception, based on historical information, current conditions, and reasonable and supportable forecasts. The new guidance is effective for us in our fiscal year beginning in 2023. We are evaluating the impact of adoption of the new standard on our consolidated financial statements. The FASB has issued guidance related to the accounting for share-based compensation to nonemployees, which eliminates the separate accounting model for nonemployee share-based payment awards and generally requires companies to account for share-based payment transactions with nonemployees in the same way as share-based payment transactions with employees. Under the new guidance, nonemployee share-based payment transactions are measured at the grant-date fair value and are no longer remeasured at the then-current fair values at each reporting date until the share options have vested. The amended guidance is effective for our annual financial statements for the fiscal year beginning on July 1, 2020 and for interim periods beginning in the subsequent fiscal year. We do not anticipate the adoption of this guidance to have a significant effect on our results of operations. The FASB has issued guidance regarding when internal-use software development costs should be capitalized or charged to expense. Depending upon on the nature of the costs and the project stage in which they are incurred. Capitalized development costs are subject to amortization and impairment guidance consistent with existing internal-use software development cost guidance. The guidance is applicable for us in our fiscal year beginning in 2023 with early adoption permitted, including adoption in an interim period. We are evaluating the impact of adoption of the new standard on our financial statements. The FASB has issued guidance clarifying the interactions between various standards governing investments in equity securities. The new guidance addresses accounting for the transition into and out of the equity method and measurement of certain purchased options and forward contracts to acquire investments. The standard is effective for us for annual and interim periods in our fiscal year beginning in 2022, with early adoption permitted. Adoption of the standard requires changes to be made prospectively. We are evaluating the impact of adoption of the new standard on our consolidated financial statements.

Business Combination

Business Combination	9 Months Ended
	Mar. 31, 2020
Business Combination [Abstract]
Business Combination	Note 3 – Business Combination On January 15, 2020, we closed on a stock purchase agreement with substantially all of the shareholders of Solo pursuant to which we acquired all right, title and interest in 80.40% of the issued and outstanding capital stock of Solo, calculated on a fully diluted basis. As a result of our investment, Solo became a controlled subsidiary and we commenced consolidation of Solo on January 15, 2020. Our preliminary estimate of acquisition date fair value of the consideration transferred for Solo was $17.6 million. We are in the process of completing a valuation of contingent consideration, which is a complex financial instrument. Due to the complexity of this financial instrument the completion of our valuation is still in process and therefore, we have not recorded an estimated liability as of March 31, 2020. The preliminary fair value of consideration recorded consisted of the following (in thousands): Preliminary Common shares issued $ 17,550 We incurred $0.2 million of transaction costs directly related to the acquisition that is reflected in selling, general and administrative expenses in our condensed consolidated statement of operations. The 1,950,000 shares of our common stock were valued at $9 per share, the closing price of a share of our common stock on the date of acquisition. In addition to the above consideration, we have agreed to pay contingent consideration in the form of fees payable to the legacy Solo shareholders equal to the lesser of (i) $0.01 per solo*TAG ™ ™ ™ ™ We have an option to acquire the noncontrolling interests in Solo during the 12 months following the close for either cash or shares. Beginning with the expiration of our option, the noncontrolling interests in Solo have a 3-month option to acquire between 40% and 55% of Solo back from us for cash. The terms of this option will result in our accounting for the instrument as a derivative. Due to the complexity of the option we have not yet completed our valuation of the option and will record the option at fair value as of the date of acquisition when the valuation is complete. The following table summarizes the preliminary fair values of assets acquired and liabilities assumed as of the date of acquisition (in thousands): Preliminary Cash $ 101 Accounts receivable 13 Prepaid expenses 22 Intangible assets and goodwill 23,138 Furniture, fixtures and equipment 15 Accounts payable and accrued expenses (876 ) Fair value of noncontrolling interests (4,863 ) Net assets acquired $ 17,550 The excess of purchase consideration over the preliminary fair value of assets acquired and liabilities assumed will be recorded as goodwill, which is primarily attributed to the assembled workforce and expanded market opportunities, for which there is no basis for U.S. income tax purposes. The fair values assigned to identifiable assets acquired and liabilities assumed are preliminary based on management's estimates and assumptions and will change as additional information is received. We expect to finalize the valuation as soon as practicable, but not later than one year from the acquisition date. The amounts of Solo's revenue and net loss included in our condensed consolidated statement of operations from the acquisition date of January 15, 2020 to March 31, 2020 were $9,600 and $516,200, respectively. The following unaudited pro forma financial information summarizes the combined results of operations for Akerna and Solo, as though the companies were combined as of the beginning of our fiscal 2019 (in thousands). Three Months Ended Nine Months Ended 2020 2019 2020 2019 Revenues $ 3,071 $ 2,328 $ 9,570 $ 7,202 Net loss (5,521 ) (2,763 ) (14,660 ) (7,460 ) The pro forma financial information for all periods presented above has been calculated after adjusting the results of Solo to reflect the business combination accounting effects resulting from this acquisition, including the amortization expense from acquired intangible assets as though the acquisition occurred as of the beginning of the Company's fiscal year 2020. As noted above, the allocation is preliminary and changes to the value of the contingent consideration and finalization of our valuation could result in changes to the amount of amortization expense from acquired intangible assets included in the pro forma financial information presented above. The Akerna historical condensed consolidated financial statements have been adjusted in the pro forma combined financial statements to give effect to pro forma events that are directly attributable to the business combination and factually supportable. The pro forma financial information is for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place at the beginning of the Company's fiscal 2020.

Loss Per Share

Loss Per Share	9 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Loss Per Share	Note 4 - Loss Per Share Basic net loss per share is calculated by dividing net loss attributable to Akerna stockholders by the weighted-average number of shares of common stock outstanding. Diluted net loss per common share is calculated by giving effect to all potentially dilutive common stock, including warrants, restricted stock awards and restricted stock units. The dilutive effect of outstanding awards is reflected in diluted earnings per share by application of the treasury stock method and excludes potential common stock when the effect would be anti-dilutive. The weighted-average number of shares outstanding used in the computation of diluted earnings per share does not include the effect of potential outstanding common shares that would have been anti-dilutive for the period. There were no potentially outstanding shares as of March 31, 2019. The table below details potentially outstanding shares on a fully diluted basis as of March 31, 2020 that were not included in the calculation of diluted earnings per share and the weighted average amounts of potentially outstanding shares that would have been dilutive had we reported net income for the three and nine months ended March 31, 2020: March 31, 2020 Weighted Average Fully Diluted Three Months Ended Nine Months Ended Warrants 5,813,804 5,813,804 5,840,644 Restricted Stock Units 325,121 22,620 12,924 Restricted Stock Awards 75,654 - - Total 6,214,579 5,836,424 5,853,568

Stockholders' Equity and Stock-

Stockholders' Equity and Stock-Based Compensation	9 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Stockholders' Equity and Stock-Based Compensation	Note 5 – Stockholders' Equity and Stock-Based Compensation A summary of our unvested Restricted Shares and Restricted Stock Units ("RSUs") activity for the nine months ended March 31, 2020 is presented in the table below: Restricted Restricted Total Weighted Average Grant Date Fair Value Nonvested at July 1, 2019 215,063 - 215,063 $ 11.99 Granted - 359,554 359,554 7.64 Vested (86,654 ) (10,223 ) (96,877 ) 11.40 Forfeited (52,755 ) (24,210 ) (76,965 ) 10.04 Nonvested at March 31, 2020 75,654 325,121 400,775 $ 8.61 For the three and nine months ended March 31, 2020, stock-based compensation expense related to the ratable amortization of the unvested Restricted Shares and RSUs was $0.3 million and $0.8 million, respectively, and $3.1 million of total unrecognized costs related to Restricted Shares and RSUs will be ratably recognized over an estimated weighted average remaining vesting period of 3.2 years. Warrants A summary of the status of outstanding warrants to purchase common stock at March 31, 2020 and the changes during the nine months then ended, is presented in the following table: Shares Weighted Weighted Outstanding at July 1, 2019 6,183,115 $ 11.50 3.72 Issued - - - Exercised (369,311 ) 11.50 - Expired/cancelled - - - Outstanding at March 31, 2020 5,813,804 $ 11.50 2.89 There was no aggregate intrinsic value for the warrants outstanding as of March 31, 2020.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 6 - Commitments and Contingencies Operating Leases We lease office facilities under non-cancelable operating leases. Rent expense for the three months ended March 31, 2020 and 2019, was $67,000 and $36,000, respectively. Rent expense for the nine months ended March 31, 2020 and 2019, was $143,000 and $115,000, respectively. On September 30, 2019, we entered into an agreement, or the Office Lease, to lease our new headquarters located at 1630 Welton Street, Denver, Colorado, 80202. The Office Lease commenced on February 24, 2020 and expires January 31, 2022. We have paid a security deposit equal to one month's rent, which is recorded in intangibles and other assets on our condensed consolidated balance sheet. The monthly payments of $41,925 are subject to a 4% annual increase at each anniversary of the commencement date during the term of the Office Lease. Rent expense related to this lease is recognized on a straight-line basis over the noncancelable term of the lease. Future minimum lease payments to be made pursuant to the Office Lease and other leases are $124,000 for the remainder of the year ended June 30, 2020; $530,000 for the year ended June 30, 2021; and $316,000 for the year ended June 30, 2022. Compensation Agreement with Jessica Billingsley On November 11, 2019, the Compensation Committee of our Board of Directors established the terms upon which Ms. Billingsley, our Chief Executive Officer, may earn a bonus for the fiscal year ended June 30, 2020. The Compensation Committee determined that Ms. Billingsley will be eligible for a bonus derived from the same targets with respect to her bonuses in fiscal year 2019, which is determined based upon our performance relative to the following four budget components: platform recurring revenue; government recurring revenue; services revenue; and net income. However, during fiscal year 2020 any bonus resulting from outperformance relative to budget may be paid in cash, stock, or a combination thereof at the sole discretion of the Compensation Committee. In addition, the Compensation Committee determined that during fiscal year 2020, Ms. Billingsley is eligible to earn a performance based incentive of $250,000, payable in stock, whereby (a) 50% of the bonus is automatically granted if our stock price/shareholder return increases by 15% (measuring point starts at $10 per share) with respect to the consecutive 20-day volume weighted average price prior to and including June 30, 2020, and (b) the remaining 50% of the bonus may be paid at the sole discretion of the Compensation Committee. Letter-of-Credit As of March 31, 2020, we had a standby letter-of-credit with a bank in the amount of $500,000, which was classified as restricted cash on the balance sheets. The beneficiary of the letter-of-credit is an insurance company. The letter-of-credit will expire on June 22, 2020. Litigation From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. We will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. The accrual for a litigation loss contingency might include, for example, estimates of potential damages, outside legal fees and other directly related costs expected to be incurred. As of March 31, 2020, and through the date these financial statements were issued, there were no legal proceedings requiring recognition or disclosure in the financial statements.

Equity Method Investment and Re

Equity Method Investment and Related Party Transaction	9 Months Ended
	Mar. 31, 2020
Investments [Abstract]
Equity Method Investment and Related Party Transaction	Note 7 – Equity Method Investment and Related Party Transaction Investment in and License Agreement with Zol Solutions, Inc. On October 7, 2019, we participated in an offering of preferred stock of Zol Solutions, Inc. ("ZolTrain") along with other investors in which we purchased 203,000 shares of Series Seed Preferred Stock (the "ZolTrain Preferred") for a purchase price of $250,000, which represents a noncontrolling interest in ZolTrain. The ZolTrain Preferred is convertible into shares of common stock of ZolTrain at a conversion rate of $1.232 per share at the option of the holder and contains certain anti-dilution protection in the event of certain future issuances of securities by ZolTrain. We are entitled to vote the number of common shares in which the ZolTrain Preferred is convertible into at any meeting of the ZolTrain stockholders. The ZolTrain Preferred also provides us with rights of first refusal with respect to newly issued securities of ZolTrain as well as issued and outstanding securities of ZolTrain that are offered to third parties. In connection with the agreement, Nina Simosko, our Chief Revenue Officer, was appointed as one of three members of ZolTrain's board of directors. Ms. Simosko may only be removed from the ZolTrain board by us and we retain the right to fill the vacancy. We have determined that ZolTrain is a VIE for accounting purposes. However, we are not required to consolidate ZolTrain in our financial statements because we are not ZolTrain's primary beneficiary. As of March 31, 2020, our maximum exposure to loss was equal to the carrying value of our initial investment of $250,000. We have concluded that the ZolTrain Preferred is in substance common stock because the liquidation preference provided is not substantive, the equity method of accounting is applicable to in substance common stock. As a result of our representation on the board of directors, we determined that we can exert significant influence over the day to day operations of ZolTrain therefore; we account for this investment using the equity method of accounting, which requires we recognize our share of the ZolTrain operations in our results of operations. Subsequent to our investment, we entered into a nonexclusive license/reseller agreement with ZolTrain, effective October 24, 2019, to provide ZolTrain's online cannabis training platform as a co-branded integration option into our MJ Platform and Leaf Data Systems, which is a related party transaction. ZolTrain will share subscription-based revenue generated from our customers with us. The amount of the share of revenue for each of us and ZolTrain will be depend on both (a) the number of training modules accessed by a customer and (b) which party created the accessed content. In addition to the revenue sharing arrangement, the license/reseller agreement provides us with the right to receive additional consideration from ZolTrain in the form of an equity earnout if certain revenue milestones are achieved during 2020, 2021, and 2022. Our ability to recognize revenue from the additional earnout consideration in the future will mainly depend on whether it becomes probable that such revenue milestones will be achieved. We have not recognized any revenue subject to this license agreement for the three and nine months ended March 31, 2020.

Subsequent Events

Subsequent Events	9 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 8 — Subsequent Events Business Combinations On April 10, 2020, we acquired 100% of the outstanding stock of Trellis Solutions, Inc., or Trellis, a cannabis cultivation management and compliance software company. In exchange for the stock of Trellis, we issued 349,650 shares of common stock, valued at $7.24 per share, the closing price of a share of our common stock on the date of acquisition, or $2.5 million. Additionally, Trellis' selling shareholders are entitled to contingent consideration based on annualized net new recurring revenue, as defined in the agreement, generated in September 2020, to be paid in Akerna stock, if any. We are in the process of valuing the contingent consideration, as well as the fair value of acquired assets and liabilities assumed. On July 7, 2020, we acquired 100% of the outstanding stock of Ample Organics, Inc., or Ample, a technology provider for cannabis businesses with a focus on providing seed-to-sale solutions to Canadian licensed producers and cannabis producers outside of Canada operating in accordance with applicable laws, to ensure cannabis cultivation operations remain compliant with the applicable regulator landscape and facilitate compliance reporting. In exchange for the stock of Ample, our wholly owned subsidiary issued 3,294,574 redeemable preferred shares, or Exchangeable Shares, valued at $25,203,491, or $7.65 per share, the closing price of a share of Akerna Common Stock on July 7, 2020. Each Exchangeable Share is exchangeable on a 1:1 basis for a share of Akerna common stock. In addition to the Exchangeable Shares, each Ample shareholder received on Contingent Value Right, or CVR, which entitles the holder to receive a portion of contingent consideration if Ample achieves certain revenue targets during the twelve-month period ending on July 7, 2021. We are in the process of valuing the contingent consideration, as well as the fair value of acquired assets and liabilities assumed. Because these acquisitions occurred subsequent to March 31, 2020, no results of operations of Trellis or Ample are included in our condensed consolidated statements of operations for the three and nine months ended March 31, 2020. It is currently impractical to disclose a preliminary purchase price allocation, value of contingent consideration or pro forma financial information combining both companies as of the earliest period presented in these financial statements as Trellis is currently in the process of closing their books and records. On July 31, 2020, we exercised our purchase option to acquire the remaining 19.6% interest in Solo in exchange for 800,000 shares of Akerna common stock. This transaction will be accounted for as a transaction between equity holders. Paycheck Protection Program Loan In April 2020, we were granted a loan, or the PPP Loan, from a lender in the aggregate amount of $2,204,600 pursuant to the Paycheck Protection Program under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act. The PPP Loan is evidenced by a promissory note dated April21, 2020, the Note. The PPP Loan bears interest at a fixed rate of 1.0% per annum, with the first six months of interest deferred from the date of the Note, has an initial term of two years from the date of the Note, and is unsecured and guaranteed by the Small Business Administration. We may prepay up to 20% of the PPP Loan amount at any time prior to maturity with no prepayment penalties. We must pay all accrued interest if we prepay greater than 20% of the PPP Loan amount and the PPP Loan has been sold on the secondary market. The Note provides for customary events of default. The PPP Loan may be accelerated upon the occurrence of an event of default. The PPP Loan may be forgiven in accordance with the terms of the CARES Act. Principal amount of the PPP Loan not forgiven and accrued interest are to be repaid in 18 equal monthly installments beginning seven months from the date of the disbursement of the PPP Loan. We applied for the PPP Loan and received the proceeds from the PPP Loan prior to the issuance of the recent guidance from the United States Treasury Department and U.S. Small Business Administration on April23, 2020. We are currently evaluating the impact this guidance has on Akerna and the PPP Loan. Convertible Notes Transaction On June 8, 2020, we entered into a Securities Purchase Agreement, or SPA, with two institutional investors, or the Holders, to sell a new series of senior secured convertible notes, or the Convertible Notes, of Akerna in a private placement to the Holders, in the aggregate principal amount of $17,000,000 having an aggregate original issue discount of 12%, and ranking senior to all outstanding and future indebtedness of Akerna. The Convertible Notes were sold on June 9, 2020 with an original issue discount pursuant to which the Holders paid $880 per each $1,000 in principal amount of the Convertible Notes. The Convertible Notes do not bear interest except upon the occurrence of an event of default, in which event the applicable rate will be 15.00% per annum. The Convertible Notes mature on June 1, 2023, are payable in installments beginning on October 1, 2020, and may not be prepaid. The Convertible Notes are convertible at any time, at the election of the Holders and subject to certain limitations, into shares of common stock at a rate equal to the amount of principal, interest, if any, and unpaid late charges, if any, divided by a conversion price of $11.50. Under the terms of the Convertible Notes, the Convertible Notes are convertible at any time, in whole or in part, at the option of the holders thereof, into shares of common stock at a rate equal to the amount of principal, interest (if any) and unpaid late charges (if any), divided by a conversion price of $11.50. In connection with the occurrence of an event of default, the Holders of the Convertible Notes will be entitled to convert all or any portion of the Convertible Notes at an alternate conversion price equal to the lower of (i) the conversion price then in effect, or (ii) 80% of the lower of (x) the volume weighted average price, or VWAP, of the common stock as of the trading day immediately preceding the applicable date of determination, or (y) the quotient of (A) the sum of the VWAP of the common stock for each of the two trading days with the lowest VWAP of the common stock during the ten (10) consecutive trading day period ending and including the trading day immediately prior to the applicable date of determination, divided by (B) two, but not less than $1.92. The SPA contains customary representations and warranties of the Holders and the Company regarding the purchase and offer and sale of the Notes.

Revisions of Previously Issued

Revisions of Previously Issued Financial Statements	9 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Revisions of Previously Issued Financial Statements	Note 9 – Revisions of Previously Issued Financial Statements During the course of preparing the Quarterly Report on Form 10-Q for the three months ended September 30, 2019, we identified certain previously duplicated revenues, which resulted in the overstatement of total assets and revenue during the periods outlined below, and the understatement of net losses for the periods outlined below. Additionally, during the course of preparing our Annual Report on Form 10-K for the fiscal year ended June 30, 2019, we identified certain costs of revenue related to consulting services previously being recorded in operating expenses, which resulted in the overstatement of the gross profit for each of the quarters during the fiscal year ended June 30, 2019. We assessed the materiality of these errors on prior periods' financial statements and concluded that the errors were not material to any prior annual or interim periods, but the cumulative adjustments necessary to correct the errors would be material if we recorded the corrections the period in which the errors were identified. In accordance with GAAP, we are revising the prior periods' financial statements when they are next issued. See Item. 4 of Part I, Controls and Procedures. The tables below disclose the effects on the financial statements included in this Quarterly Report on Form 10-Q and the financial statements yet to be reissued: Year Ended June 30, 2018 As Adjustment As Consolidated Balance Sheet Total assets $ 3,017,731 $ (223,766 ) $ 2,793,965 Total liabilities 1,393,902 - 1,393,902 Total stockholders' equity 1,623,829 (223,766 ) 1,400,063 Net loss (1,623,182 ) (72,501 ) (1,695,683 ) Net loss per share (0.30 ) (0.31 ) As of March 31, 2019 As Adjustment As Condensed Consolidated Balance Sheet Total assets $ 8,199,718 $ (320,434 ) $ 7,879,284 Total liabilities 3,059,378 - 3,059,378 Total stockholders' equity 5,140,340 (320,434 ) 4,819,906 Three Months Ended March 31, 2019 As Adjustment As Condensed Consolidated Statements of Operations Total revenue $ 2,327,880 $ - $ 2,327,880 Cost of revenue 1,042,403 124,079 1,166,482 Gross profit 1,285,477 (124,079 ) 1,161,398 Operating expenses 3,788,644 (124,079 ) 3,664,565 Net loss (2,490,103 ) - (2,490,103 ) Net loss per share (0.41 ) (0.41 ) Nine Months Ended March 31, 2019 As Adjustment As Condensed Consolidated Statements of Operations Total revenue 7,297,859 (96,668 ) 7,201,191 Cost of revenue 3,197,437 353,175 3,550,612 Gross profit 4,100,422 (449,843 ) 3,650,579 Operating expenses 10,671,159 (353,175 ) 10,317,984 Net loss (6,483,489 ) (96,668 ) (6,580,157 ) Net loss per share (1.10 ) (1.13 ) Year Ended June 30, 2019 As Adjustment As Consolidated Balance Sheet Total assets 24,522,671 (320,434 ) 24,202,237 Total liabilities 2,442,503 - 2,442,503 Total stockholders' equity 22,080,168 (320,434 ) 21,759,734 Consolidated Statements of Operations Total revenue 10,919,785 (96,668 ) 10,823,117 Cost of revenue 4,633,844 - 4,633,844 Gross profit 6,285,941 (96,668 ) 6,189,273 Operating expenses 18,701,619 - 18,701,619 Net loss (12,306,547 ) (96,668 ) (12,403,215 ) Net loss per share (2.04 ) (2.05 )

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. Certain footnotes and other financial information normally required by accounting principles generally accepted in the United States of America, or GAAP, have been condensed or omitted in accordance with such rules and regulations. In management's opinion, these condensed consolidated financial statements have been prepared on the same basis as our annual consolidated financial statements and notes thereto and include all adjustments, consisting of normal recurring items, considered necessary for the fair presentation. The operating results for the three and nine months ended March 31, 2020 are not necessarily indicative of the results that may be expected for the year ending June 30, 2020. The condensed consolidated balance sheet for the year ended June 30, 2019 has been derived from our audited financial statements at that date but does not include all disclosures and financial information required by GAAP for complete financial statements. The information included in this quarterly report on Form 10-Q should be read in conjunction with our consolidated financial statements and notes thereto for the year ended June 30, 2019, which were included in our annual report on Form 10-K filed on September 23, 2019.
Principles of Consolidation	Principles of Consolidation Our accompanying condensed consolidated financial statements include the accounts of Akerna, our wholly owned subsidiaries and those entities in which we otherwise have a controlling financial interest. All significant intercompany balances and transactions have been eliminated in consolidation. We evaluate our ownership interests, contractual rights and other interests in entities to determine if the entities are variable interest entities, or VIEs, when we have a variable interest in those entities. Generally, a VIE is a legal entity in which the equity investors do not have the characteristics of a controlling financial interest or the equity investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support. These evaluations can be complex and involve judgment and the use of estimates and assumptions based on available historical information. If we determine that we hold a variable interest in a VIE and we are the primary beneficiary of the VIE, we must consolidate the VIE in our financial statements. In determining whether we are the primary beneficiary of a VIE, we consider qualitative and quantitative factors, including, but not limited to: which activities most significantly impact the VIE's economic performance and which party controls such activities; the amount and characteristics of our investment; the obligation or likelihood for us or other investors to provide financial support; and the similarity with and significance to our business activities and the business activities of the other investors. Significant judgments related to these determinations include estimates about the current and future fair values and performance of these VIE's operations and general market conditions. We determine whether we are the primary beneficiary of a VIE upon our initial involvement with the VIE and reassess our status on an ongoing basis.
Use of Estimates	Use of Estimates The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the financial statements and accompanying notes thereto. Actual results could differ materially from those estimates.
Accounts Receivable, Net	Accounts Receivable, Net We maintain an allowance for doubtful accounts equal to the estimated uncollectible amounts based on our historical collection experience and review of the current status of trade accounts receivable. The allowance for doubtful accounts was $0.5 million as March 31, 2020 and $0.2 million as of June 30, 2019.
Concentrations of Credit Risk	Concentrations of Credit Risk We grant credit in the normal course of business to our customers. We periodically perform credit analysis and monitor the financial condition of our customers to reduce credit risk. During the three months ended March 31, 2020, one government customer accounted for 25% of total revenues. At March 31, 2020, the same government customer and one other government customer accounted for 24% and 16% of net accounts receivable, respectively. During the three months ended March 31, 2019, one government customer accounted for 33% of total revenues. At June 30, 2019, the same government customer and one other government customer accounted for 33% and 24% of net accounts receivable, respectively. During the nine months ended March 31, 2020, one government customer accounted for 24% and one consulting customer accounted for 11% of total revenues. During the nine months ended March 31, 2019, two government customers accounted for 35% and 11% of total revenues, respectively.
Equity Method Investments	Equity Method Investments We make strategic investments in privately held equity securities of companies who provide technology solutions that are complementary to ours. When we can exert significant influence over, but do not control, the investee's operations, through voting rights or representation on the investee's board of directors, we account for the investment using the equity method of accounting. We record our share in the investee's earnings in the consolidated statement of operations. We assess our investment for other-than-temporary impairment when events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable and recognize an impairment loss to adjust the investment to its then current fair value.
Intangible Assets Acquired through Business Combinations	Intangible Assets Acquired through Business Combinations Intangible assets are amortized over their estimated useful lives. We evaluate the estimated remaining useful life of our intangible assets when events or changes in circumstances indicate an adjustment to the remaining amortization may be needed. We similarly evaluate the recoverability of these assets upon events or changes in circumstances indicate a potential impairment. Recoverability of these assets is measured by comparing the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate. If the undiscounted cash flows used in the test for recoverability are less than the carrying amount of these assets, the carrying amount of such assets is reduced to fair value There were no impairments of intangible assets during the nine months ended March 31, 2020 or 2019.
Goodwill Impairment Assessment	Goodwill Impairment Assessment We evaluate and test the recoverability of our goodwill for impairment at least annually during the second quarter of each fiscal year or more often if circumstances indicate that goodwill may not be recoverable.
Business Combinations	Business Combinations We use our best estimates and assumptions to assign fair value to the tangible and intangible assets acquired and liabilities assumed at the acquisition date. Our estimates are inherently uncertain and subject to refinement. During the measurement period, which may be up to one year from the acquisition date, we continue to collect information and reevaluate these estimates and assumptions quarterly and record any adjustments to our preliminary estimates to goodwill. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded in our condensed consolidated statement of operations. In the event we acquire an entity with which we have a preexisting relationship, we will recognize a gain or loss to settle that relationship as of the acquisition date within the condensed consolidated statements of operations. In the event that we acquire an entity in which we previously held a noncontrolling interest, the difference between the fair value of the shares as of the date of the acquisition and the carrying value of our investment is recorded as a gain or loss in the condensed consolidated statement of operations.
Revenue Recognition	Revenue Recognition We derive our revenues primarily from the following sources: software revenues, which are primarily comprised of subscription fees from government and commercial customers accessing our enterprise cloud computing services and from customers paying for additional support beyond the standard support that is included in the basic subscription fees; and consulting services provided to operators interested in integrating our platform into their respective operations, such services include: assessing compliance requirements, monitoring systems and readiness; assisting with the application process; and evaluating the operator's inspection readiness and business plan. We commence revenue recognition when there is persuasive evidence of an arrangement, the service has been or is being provided to the customer, the collection of the fees is reasonably assured, and the amount of fees to be paid by the customer is fixed or determinable. Software Revenue Software revenue primarily consists of subscription revenue that is recognized ratably over the term of the contractual period, beginning when access to the applicable software is provided to the customer. We typically invoice customers at the beginning of the term, in multi-year, annual, quarterly, or monthly installments. When collection of fees occurs in advance of service delivery, revenue recognition is deferred until such services are delivered. Revenue for implementation fees is recognized ratably over the expected term of the agreement, including expected renewals. We include service level commitments to customers warranting certain levels of uptime reliability and performance and permitting those customers to receive credits if those levels are not met. In addition, customer contracts often include: specific obligations that require us to maintain the availability of the customer's data through the service and that customer content is secured against unauthorized access or loss; and indemnity provisions whereby we indemnify customers from third-party claims asserted against them that result from our failure to maintain the availability of their content or securing the same from unauthorized access or loss. To date, we have not incurred any material costs as a result of such commitments. Any such credits or payments made to customers under these arrangements are recorded as a reduction of revenue. Consulting Services Revenue Consulting services revenue consists of contracts with fixed terms and fee structures based upon the volume and activity, or fixed price contracts for consulting and strategic services. When these services are not combined with subscription revenues as a single unit of account, as discussed below, these revenues are recognized as services are rendered and accepted by the customer. Other Revenues From time to time, we purchase equipment for resale to customers. Such equipment is generally drop-shipped to our customers. We recognize revenue as the products are delivered. Cost of Revenue Cost of revenue consists primarily of costs related to providing subscription and other services to our customers, including employee compensation and related expenses for datacenter operations, customer support and professional services personnel, payments to outside technology service providers, security services and other tools. Deferred Revenue Deferred revenue primarily consists of payments received in advance of revenue recognition from subscription services described above and is recognized as the revenue recognition criteria are met. The deferred revenue balance is influenced by several factors, including seasonality, the compounding effects of renewals, invoice duration, invoice timing, size and new business within the year. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as deferred revenue, which is a current liability on the accompany condensed consolidated balance sheets.
Supplemental Information Regarding Noncash Investing and Financing Activities	Supplemental Information Regarding Noncash Investing and Financing Activities During the nine months ended March 31, 2020, we acquired 80.4% of the outstanding equity interest in solo sciences inc., or Solo, in exchange for Akerna common stock valued at $17.6 million, please refer to Note 3 for additional information about the transaction and a schedule of the assets acquired and liabilities assumed in conjunction with this transaction.
Reclassifications	Reclassifications Certain prior year financial statement amounts have been reclassified for consistency with the current year presentation.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Financial Accounting Standards Board, or the FASB, has issued guidance to revise accounting for revenue from contracts with customers, which supersedes the revenue recognition requirements and industry-specific guidance currently in effect for us. The new revenue standard requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. The new revenue standard is effective for our fiscal 2020 annual reporting period and for interim periods thereafter. The new revenue standard allows for either full retrospective or modified retrospective adoption. We will adopt the new standard using the modified retrospective approach and anticipate that the timing of recognition of incremental costs of obtaining contracts will be the most significant change to our results of operations upon adoption. The FASB has issued new guidance related to the accounting for leases. The new standard establishes a right-of-use model that requires a lessee to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statement of operations. The new standard is effective for us in our fiscal year beginning in 2021. We are evaluating the impact of adoption of the new standard on our consolidated financial statements and do not anticipate a significant impact to our results of operations. The FASB has issued guidance to introduce a new model for recognizing credit losses on financial instruments based on estimated current expected credit losses, or CECL. Under the new standard, an entity is required to estimate CECL on trade receivables at inception, based on historical information, current conditions, and reasonable and supportable forecasts. The new guidance is effective for us in our fiscal year beginning in 2023. We are evaluating the impact of adoption of the new standard on our consolidated financial statements. The FASB has issued guidance related to the accounting for share-based compensation to nonemployees, which eliminates the separate accounting model for nonemployee share-based payment awards and generally requires companies to account for share-based payment transactions with nonemployees in the same way as share-based payment transactions with employees. Under the new guidance, nonemployee share-based payment transactions are measured at the grant-date fair value and are no longer remeasured at the then-current fair values at each reporting date until the share options have vested. The amended guidance is effective for our annual financial statements for the fiscal year beginning on July 1, 2020 and for interim periods beginning in the subsequent fiscal year. We do not anticipate the adoption of this guidance to have a significant effect on our results of operations. The FASB has issued guidance regarding when internal-use software development costs should be capitalized or charged to expense. Depending upon on the nature of the costs and the project stage in which they are incurred. Capitalized development costs are subject to amortization and impairment guidance consistent with existing internal-use software development cost guidance. The guidance is applicable for us in our fiscal year beginning in 2023 with early adoption permitted, including adoption in an interim period. We are evaluating the impact of adoption of the new standard on our financial statements. The FASB has issued guidance clarifying the interactions between various standards governing investments in equity securities. The new guidance addresses accounting for the transition into and out of the equity method and measurement of certain purchased options and forward contracts to acquire investments. The standard is effective for us for annual and interim periods in our fiscal year beginning in 2022, with early adoption permitted. Adoption of the standard requires changes to be made prospectively. We are evaluating the impact of adoption of the new standard on our consolidated financial statements.

Business Combination (Tables)

Business Combination (Tables)	9 Months Ended
	Mar. 31, 2020
Business Combination [Abstract]
Schedule of acquisition date fair value of consideration	Preliminary Common shares issued $ 17,550
Schedule of fair values of assets acquired and liabilities	Preliminary Cash $ 101 Accounts receivable 13 Prepaid expenses 22 Intangible assets and goodwill 23,138 Furniture, fixtures and equipment 15 Accounts payable and accrued expenses (876 ) Fair value of noncontrolling interests (4,863 ) Net assets acquired $ 17,550
Schedule of financial information combined results of operations	Three Months Ended Nine Months Ended 2020 2019 2020 2019 Revenues $ 3,071 $ 2,328 $ 9,570 $ 7,202 Net loss (5,521 ) (2,763 ) (14,660 ) (7,460 )

Loss Per Share (Tables)

Loss Per Share (Tables)	9 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Schedule of diluted earnings per share	March 31, 2020 Weighted Average Fully Diluted Three Months Ended Nine Months Ended Warrants 5,813,804 5,813,804 5,840,644 Restricted Stock Units 325,121 22,620 12,924 Restricted Stock Awards 75,654 - - Total 6,214,579 5,836,424 5,853,568

Stockholders' Equity and Stoc_2

Stockholders' Equity and Stock-Based Compensation (Tables)	9 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Schedule of nonvested restricted stock units activity	Restricted Restricted Total Weighted Average Grant Date Fair Value Nonvested at July 1, 2019 215,063 - 215,063 $ 11.99 Granted - 359,554 359,554 7.64 Vested (86,654 ) (10,223 ) (96,877 ) 11.40 Forfeited (52,755 ) (24,210 ) (76,965 ) 10.04 Nonvested at March 31, 2020 75,654 325,121 400,775 $ 8.61
Schedule of stock warrants	Shares Weighted Weighted Outstanding at July 1, 2019 6,183,115 $ 11.50 3.72 Issued - - - Exercised (369,311 ) 11.50 - Expired/cancelled - - - Outstanding at March 31, 2020 5,813,804 $ 11.50 2.89

Revisions of Previously Issue_2

Revisions of Previously Issued Financial Statements (Tables)	9 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of reclassifications	Year Ended June 30, 2018 As Adjustment As Consolidated Balance Sheet Total assets $ 3,017,731 $ (223,766 ) $ 2,793,965 Total liabilities 1,393,902 - 1,393,902 Total stockholders' equity 1,623,829 (223,766 ) 1,400,063 Net loss (1,623,182 ) (72,501 ) (1,695,683 ) Net loss per share (0.30 ) (0.31 ) As of March 31, 2019 As Adjustment As Condensed Consolidated Balance Sheet Total assets $ 8,199,718 $ (320,434 ) $ 7,879,284 Total liabilities 3,059,378 - 3,059,378 Total stockholders' equity 5,140,340 (320,434 ) 4,819,906 Three Months Ended March 31, 2019 As Adjustment As Condensed Consolidated Statements of Operations Total revenue $ 2,327,880 $ - $ 2,327,880 Cost of revenue 1,042,403 124,079 1,166,482 Gross profit 1,285,477 (124,079 ) 1,161,398 Operating expenses 3,788,644 (124,079 ) 3,664,565 Net loss (2,490,103 ) - (2,490,103 ) Net loss per share (0.41 ) (0.41 ) Nine Months Ended March 31, 2019 As Adjustment As Condensed Consolidated Statements of Operations Total revenue 7,297,859 (96,668 ) 7,201,191 Cost of revenue 3,197,437 353,175 3,550,612 Gross profit 4,100,422 (449,843 ) 3,650,579 Operating expenses 10,671,159 (353,175 ) 10,317,984 Net loss (6,483,489 ) (96,668 ) (6,580,157 ) Net loss per share (1.10 ) (1.13 ) Year Ended June 30, 2019 As Adjustment As Consolidated Balance Sheet Total assets 24,522,671 (320,434 ) 24,202,237 Total liabilities 2,442,503 - 2,442,503 Total stockholders' equity 22,080,168 (320,434 ) 21,759,734 Consolidated Statements of Operations Total revenue 10,919,785 (96,668 ) 10,823,117 Cost of revenue 4,633,844 - 4,633,844 Gross profit 6,285,941 (96,668 ) 6,189,273 Operating expenses 18,701,619 - 18,701,619 Net loss (12,306,547 ) (96,668 ) (12,403,215 ) Net loss per share (2.04 ) (2.05 )

Description of Business, Liqu_2

Description of Business, Liquidity and Capital Resources (Details)	9 Months Ended
	Mar. 31, 2020USD ($)
Description of Business, Liquidity and Capital Resources (Textual)
Costs incurred	$ 1,800,000
Cost reduction plan, description	During the fourth quarter 2020 that we expect to reduce recurring operating expenses between $2 million and $3 million annually.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details)	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2020USD ($)Customers	Mar. 31, 2019Customers	Mar. 31, 2020USD ($)Customers	Mar. 31, 2019Customers	Jun. 30, 2019USD ($)Customers
Summary of Significant Accounting Policies (Textual)
Allowance for doubtful accounts | $	$ 500,000		$ 500,000		$ 200,000
Equity interest, percentage	80.40%		80.40%
Common stock valued | $			$ 17,600,000
One Other Government Customer [Member] | Net accounts receivable [Member]
Summary of Significant Accounting Policies (Textual)
Concentration risk percentage			16.00%
Number of customer			1
Same Government Customer [Member] | Net accounts receivable [Member]
Summary of Significant Accounting Policies (Textual)
Concentration risk percentage			24.00%		33.00%
Number of customer			1		1
One Government Customer [Member] | Net accounts receivable [Member]
Summary of Significant Accounting Policies (Textual)
Concentration risk percentage	24.00%
Number of customer	1
One Government Customer [Member] | Total revenues [Member]
Summary of Significant Accounting Policies (Textual)
Concentration risk percentage	25.00%	33.00%	24.00%
Number of customer	1	1	1
One Consulting Customer [Member] | Total revenues [Member]
Summary of Significant Accounting Policies (Textual)
Concentration risk percentage			11.00%
Number of customer			1
Two Government Customers [Member] | Total revenues [Member]
Summary of Significant Accounting Policies (Textual)
Concentration risk percentage				35.00%
Number of customer				2
Two Government Customers One [Member] | Total revenues [Member]
Summary of Significant Accounting Policies (Textual)
Concentration risk percentage				11.00%
Number of customer				2

Business Combination (Details)

Business Combination (Details)	Mar. 31, 2020USD ($)
Business Combination [Abstract]
Common shares issued	$ 17,550

Business Combination (Details 1

Business Combination (Details 1)	Mar. 31, 2020USD ($)
Business Combination [Abstract]
Cash	$ 101
Accounts receivable	13
Prepaid expenses	22
Intangible assets and goodwill	23,138
Furniture, fixtures and equipment	15
Accounts payable and accrued expenses	(876)
Fair value of noncontrolling interests	(4,863)
Net assets acquired	$ 17,550

Business Combination (Details 2

Business Combination (Details 2) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Business Combination [Abstract]
Revenues	$ 3,071	$ 2,328	$ 9,570	$ 7,202
Net loss	$ (5,521)	$ (2,763)	$ (14,660)	$ (7,460)

Business Combination (Details T

Business Combination (Details Textual) - USD ($)	Jan. 15, 2020	Mar. 31, 2020	Mar. 31, 2020
Business Combination (Textual)
Bussiness combination interst	80.40%
Fair value of consideration transfered	$ 17,600,000
Selling general and administrative expenses			$ 200,000
Common stock per share		$ 9	$ 9
Contingent consideration, description			(i) $0.01 per solo*TAG™ and solo*CODE™ sold or (ii) 7% of net revenue. The fees will be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon us no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAG™ and solo*CODE™, which is December 1, 2029. This fee represents contingent consideration and will be recorded at fair value as of the date of acquisition. As noted above due to the complexity of this valuation we have not included an estimated liability as of March 31, 2020 and will record the contingent consideration liability when we have completed the valuation. Contingent consideration will be recorded at fair value with changes in fair value being recognized in earnings at each reporting period.
Revenues	$ 9,600		$ 516,200
Common stock		1,950,000	1,950,000
Minimum [Member]
Business Combination (Textual)
Non controlling interest for cash		40.00%
Maximum [Member]
Business Combination (Textual)
Non controlling interest for cash		55.00%

Loss Per Share (Details)

Loss Per Share (Details) - shares	3 Months Ended	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2020
Weighted average number of shares outstanding diluted, Shares	5,836,424	5,853,568
Weighted average number of shares outstanding fully diluted, Shares	6,214,579
Warrants [Member]
Weighted average number of shares outstanding diluted, Shares	5,813,804	5,840,644
Weighted average number of shares outstanding fully diluted, Shares	5,813,804
Restricted Stock Units [Member]
Weighted average number of shares outstanding diluted, Shares	22,620	12,924
Weighted average number of shares outstanding fully diluted, Shares	325,121
Restricted Stock Awards [Member]
Weighted average number of shares outstanding diluted, Shares
Weighted average number of shares outstanding fully diluted, Shares	75,654

Stockholders' Equity and Stoc_3

Stockholders' Equity and Stock-Based Compensation (Details) - Restricted Shares [Member]	9 Months Ended
	Mar. 31, 2020$ / sharesshares
Restricted Shares
Beginning balance, nonvested	215,063
Granted
Vested	(86,654)
Forfeited	(52,755)
Ending balance, nonvested	75,654
Restricted Stock Units
Beginning balance, nonvested
Granted	359,554
Vested	(10,223)
Forfeited	(24,210)
Ending balance, nonvested	325,121
Beginning balance, nonvested	215,063
Granted	359,554
Vested	(96,877)
Forfeited	(76,965)
Ending balance, nonvested	400,775
Weighted Average Grant Date Fair
Beginning balance | $ / shares	$ 11.99
Granted | $ / shares	7.64
Vested | $ / shares	11.40
Forfeited | $ / shares	10.04
Ending balance | $ / shares	$ 8.61

Stockholders' Equity and Stoc_4

Stockholders' Equity and Stock-Based Compensation (Details 1)	9 Months Ended
	Mar. 31, 2020$ / sharesshares
Equity [Abstract]
Beginning balance, outstanding | shares	6,183,115
Issued | shares
Exercised | shares	(369,311)
Expired/cancelled | shares
Ending balance, outstanding | shares	5,813,804
Beginning balance | $ / shares	$ 11.50
Issued | $ / shares
Exercised | $ / shares	11.50
Expired/cancelled | $ / shares
Ending balance | $ / shares	$ 11.50
Beginning balance, outstanding	3 years 8 months 19 days
Ending balance, outstanding	2 years 10 months 21 days

Stockholders' Equity and Stoc_5

Stockholders' Equity and Stock-Based Compensation (Details Textual) - Restricted Shares [Member] - USD ($)	3 Months Ended	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2020
Stockholders' Equity and Stock-Based Compensation (Textual)
Stock-based compensation expenses related to unvested Restricted Shares	$ 300,000	$ 800,000
Total unrecognized costs	$ 3,100,000	$ 3,100,000
Estimated remaining vesting period	3 years 2 months 12 days	3 years 2 months 12 days

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	Nov. 11, 2019	Sep. 30, 2019	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019	Jun. 30, 2019
Commitments and Contingencies (Textual)
Rent expense			$ 67,000	$ 36,000	$ 143,000	$ 115,000
Restricted cash			500,000		500,000		$ 500,000
Annual rent payments					$ 500,000
Annual rent payments, percentage					4.00%
Future minimum lease payments remainder of fiscal year ended June 30, 2020			124,000		$ 124,000
Future minimum lease payments of fiscal year ended June 30, 2021			530,000		530,000
Future minimum lease payments of fiscal year ended June 30, 2022			316,000		316,000
Annual indexation increases			$ 41,925		$ 41,925
Letter-of-credit, description					The letter-of-credit will expire on June 22, 2020.
Office lease expire, description		The Office Lease commenced on February 24, 2020 and expires January 31, 2022.
Jessica Billingsley [Member]
Commitments and Contingencies (Textual)
Performance based incentive, description	(a) 50% of the bonus is automatically granted if our stock price/shareholder return increases by 15% (measuring point starts at $10 per share) with respect to the consecutive 20-day volume weighted average price prior to and including June 30, 2020, and (b) the remaining 50% of the bonus may be paid at the sole discretion of the Compensation Committee.
Annual salary	$ 250,000

Equity Method Investment and _2

Equity Method Investment and Related Party Transaction (Details) - USD ($)	Oct. 07, 2019	Mar. 31, 2020	Jun. 30, 2019
Equity Method Investment and Related Party Transaction (Textual)
Carrying value of our initial investment		$ 250,000
Zol Solutions, Inc. [Member]
Equity Method Investment and Related Party Transaction (Textual)
Preferred stock purchased shares	203,000
Preferred stock purchased share value	$ 250,000
Convertible into shares of common stock per share	$ 1.232
Carrying value of our initial investment		$ 250,000

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)	Jul. 07, 2020	Jun. 09, 2020	Jul. 31, 2020	Apr. 30, 2020	Mar. 31, 2020	Jun. 08, 2020	Apr. 10, 2020
Subsequent Events (Textual)
Issued and outstanding capital interest							100.00%
Common stock acquition value							$ 2,500,000
Common stock, issued							349,650
Common stock per share							$ 7.24
Business combination, description	We acquired 100% of the outstanding stock of Ample Organics, Inc., or Ample, a technology provider for cannabis businesses with a focus on providing seed-to-sale solutions to Canadian licensed producers and cannabis producers outside of Canada operating in accordance with applicable laws, to ensure cannabis cultivation operations remain compliant with the applicable regulator landscape and facilitate compliance reporting. In exchange for the stock of Ample, our wholly owned subsidiary issued 3,294,574 redeemable preferred shares, or Exchangeable Shares, valued at $25,203,491, or $7.65 per share, the closing price of a share of Akerna Common Stock on July 7, 2020.
Conversion price per share					$ 11.50
Description of business acquistion			We exercised our purchase option to acquire the remaining 19.6% interest in Solo in exchange for 800,000 shares of Akerna common stock.
Convertible Notes Transaction [Member]
Subsequent Events (Textual)
Aggregate amount of loan		$ 1,000				$ 17,000,000
Original issue discount						12.00%
Holders paid		$ 880
Conversion price per share					$ 11.50
Maturity date					Jun. 1, 2023
Convertible note, description					(i) the conversion price then in effect, or (ii) 80% of the lower of (x) the volume weighted average price, or VWAP, of the common stock as of the trading day immediately preceding the applicable date of determination, or (y) the quotient of (A) the sum of the VWAP of the common stock for each of the two trading days with the lowest VWAP of the common stock during the ten (10) consecutive trading day period ending and including the trading day immediately prior to the applicable date of determination, divided by (B) two, but not less than $1.92.
Event applicable rate		15.00%
Paycheck Protection Program Loan [Member]
Subsequent Events (Textual)
Aggregate amount of loan				$ 2,204,600
Loan bears interest				1.00%
Prepay loan, description				We may prepay up to 20% of the PPP Loan amount at any time prior to maturity with no prepayment penalties. We must pay all accrued interest if we prepay greater than 20% of the PPP Loan amount and the PPP Loan has been sold on the secondary market. The Note provides for customary events of default. The PPP Loan may be accelerated upon the occurrence of an event of default. The PPP Loan may be forgiven in accordance with the terms of the CARES Act. Principal amount of the PPP Loan not forgiven and accrued interest are to be repaid in 18 equal monthly installments beginning seven months from the date of the disbursement of the PPP Loan.

Revisions of Previously Issue_3

Revisions of Previously Issued Financial Statements (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2018	Sep. 30, 2018
Total assets	$ 17,896,418	$ 7,879,284	$ 17,896,418	$ 7,879,284	$ 24,202,237	$ 2,793,965
Total liabilities	4,768,516	3,059,378	4,768,516	3,059,378	2,442,503	1,393,902
Total stockholders' equity	31,817,810	(4,819,906)	31,817,810	(4,819,906)	21,759,734	1,400,063	$ 19,314,842	$ 23,317,282	$ 7,310,009	$ 9,704,380
Total revenue	3,070,546	2,327,880	9,569,638	7,201,191	10,823,117
Cost of revenues	1,420,909	1,166,482	4,457,110	3,550,612	4,633,844
Gross profit	1,649,637	1,161,398	5,112,528	3,650,579	6,189,273
Operating expenses	$ 7,133,190	3,664,565	$ 17,905,798	10,317,984	18,701,619
Net loss		$ (2,763,000)		$ (6,580,157)	$ (12,403,215)	$ (1,695,683)
Net loss per share		$ (0.41)		$ (1.12)	$ (2.05)	$ (0.31)
As Reported [Member]
Total assets		$ 8,199,718		$ 8,199,718	$ 24,522,671	$ 3,017,731
Total liabilities		3,059,378		3,059,378	2,442,503	1,393,902
Total stockholders' equity		5,140,340		5,140,340	22,080,168	1,623,829
Total revenue		2,327,880		7,297,859	10,919,785
Cost of revenues		1,042,403		3,197,437	4,633,844
Gross profit		1,285,477		4,100,422	6,285,941
Operating expenses		3,788,644		10,671,159	18,701,619
Net loss		$ (2,490,103)		$ (6,483,489)	$ (12,306,547)	$ (1,623,182)
Net loss per share		$ (0.41)		$ (1.10)	$ (2.04)	$ (0.30)
Adjustment [Member]
Total assets		$ (320,434)		$ (320,434)	$ (320,434)	$ (223,766)
Total liabilities
Total stockholders' equity		(320,434)		(320,434)	(320,434)	(223,766)
Total revenue				(96,668)	(96,668)
Cost of revenues		124,079		353,175
Gross profit		(124,079)		(449,843)	(96,668)
Operating expenses		(124,079)		(353,175)
Net loss				$ (96,668)	$ (96,668)	$ (72,501)
Net loss per share